ConvaTec : AGM Result of Meeting

RNS Number : 7191N ConvaTec Group PLC 10 May 2018

CONVATEC GROUP PLC - AGM 10 MAY 2018 - POLL RESULT

Result of Meeting

ConvaTec Group Plc ("ConvaTec"), a leading global medical products and technologies company, held its annual general meeting today. The results of the poll held in relation to the resolutions proposed at the meeting are set out below.

• 1 Receive Annual Report and Accounts

• 2 Approve the Directors' Remuneration Report

• 3 Declare Final Dividend

• 4 Re-elect Sir Christopher Gent as a Director

• 5 Re-elect Paul Moraviec as a Director

• 6 Elect Frank Schulkes as a Director

• 7 Re-elect Steve Holliday as a Director

• 8 Re-elect Jesper Ovesen as a Director

• 9 Re-elect Rick Anderson as a Director

• 10 Re-elect Kasim Kutay as a Director

• 11 Elect Ros Rivaz as a Director

• 12 Elect Regina Benjamin as a Director

• 13 Elect Margaret Ewing as a Director

• 14 Re-appoint Deloitte LLP as auditors

• 15 Authorise the Directors to agree the auditors' remuneration

1,483,108,674

1,488,939,928

1,481,688,827

1,482,717,535

1,476,891,196

1,488,985,560

1,488,564,111

1,486,522,754

1,488,488,383

• 16 Authorise allotment of shares

  1,479,661,716

• 17 Disapply pre-emption rights*

• 18 Disapply pre-emption rights in connection with an acquisition or specified capital investment*

• 19 Authorise purchase of own shares*

• 20 Authorise political donations and political expenditure

• 21 Call general meetings on 14 days' notice*

*Special Resolution

NOTES:

1.

All resolutions were passed.

• 2. Votes "For" and "Against" are expressed as a percentage of votes received.

• 3. A "Vote withheld" is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution.

• 4. Total number of shares in issue at 6.30pm on 8 May 2018 was 1,951,850,599 shares. Up to 76.39% of voting capital was instructed.

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions. The Company is listed on the London Stock Exchange (stock symbol: CTEC) and has leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care.www.convatecgroup.com

This information is provided by RNS

The company news service from the London Stock Exchange

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

###

END

This information is provided by RNS

The company news service from the London Stock Exchange

END

RAGEALSEFSSPEFF